Know Cancer

or
forgot password

Uveitis: Medico-economical and Clinical Evaluation of a Standardized Strategy for an Etiological Diagnosis


N/A
18 Years
N/A
Open (Enrolling)
Both
Uveitis

Thank you

Trial Information

Uveitis: Medico-economical and Clinical Evaluation of a Standardized Strategy for an Etiological Diagnosis


Inclusion Criteria:



- Uveitis

- Patient consulting one of the study's sites

- Age > 18 years old

- Affiliation to the French national health insurance program

- Patient agreeing to participate in the study

Exclusion Criteria:

- Positive HIV serology

- Postsurgical or posttraumatic uveitis or endophthalmitis

- Toxoplasmic uveitis

- Pathology likely to be the cause of the known uveitis

- Ophthalmic entities only diagnosed by the ophthalmic examination

- Age < 18 years old

- Patient under law protection or guardianship

- Pregnant women or those planning to be pregnant during the study

- Severe uveitis (VA < 20/200) with retinal vascularitis requiring an emergency
treatment and assessment.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

The primary outcome is the percentage of patients having an etiological diagnosis 6 months after the beginning of the study for both strategies.

Outcome Description:

Note: Only diagnoses made at the end of the standardized strategy will be numbered in this arm of the study; all diagnoses made after by the free authorized examinations in this same arm will lead to standardized strategy failure.

Outcome Time Frame:

6 months

Safety Issue:

Yes

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

2009.566/19

NCT ID:

NCT01162070

Start Date:

June 2010

Completion Date:

July 2013

Related Keywords:

  • Uveitis
  • Uveitis
  • etiological diagnosis
  • standardized strategy
  • Uveitis
  • Chorioretinitis

Name

Location